Literature DB >> 9356348

Identification of a consensus mutation in M protein of vesicular stomatitis virus from persistently infected cells that affects inhibition of host-directed gene expression.

M Ahmed1, D S Lyles.   

Abstract

In addition to its function in virus assembly, the viral matrix (M) protein of vesicular stomatitis virus (VSV) inhibits host-directed gene expression. The goal of this study was to determine whether sequence changes in M protein contribute to a reduced shut off of host gene expression in cells persistently infected with VSV. Viruses isolated from L cells persistently infected with VSV inhibited host RNA synthesis more slowly than wild-type (wt) VSV. M genes of the persistent viral population were cloned and sequenced. One mutation, an N to D change at position 163 of the protein sequence (N163D), was common to all the molecular clones. The N163D M protein was synthesized from transfected mRNA at a rate that was 30% of that of wt M protein, but was turned over at a rate that was similar to that of wt M protein. Transfection of mRNA encoding N163D M protein inhibited expression of a cotransfected target gene encoding chloramphenicol acetyl transferase (CAT), but the inhibition was 6 to 10 times less effective than transfection of equivalent amounts of wt M mRNA. This difference could not be accounted for by differences in translation of CAT mRNA. Thus, when the differences in M protein expression were taken into account, N163D M protein was 2 to 3 times less effective than wt M protein in the inhibition of host-directed gene expression, similar to the differences in host transcription observed in virus-infected cells. Point mutations in addition to the N163D mutation were found in about half of the M gene molecular clones. The M gene of an independently isolated molecular clone, N163D.2, contained two additional point mutations in its carboxy terminal region. N163D.2 M protein was highly defective in inhibition of host gene expression and was turned over more rapidly than wt M protein. These results support the idea that M gene mutations contribute to a reduced cytopathic effect in cells persistently infected with VSV. Copyright 1997 Academic Press. Copyright 1997Academic Press

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356348     DOI: 10.1006/viro.1997.8808

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  23 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release.

Authors:  H R Jayakar; K G Murti; M A Whitt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  RNA interference with measles virus N, P, and L mRNAs efficiently prevents and with matrix protein mRNA enhances viral transcription.

Authors:  Thorsten Reuter; Benedikt Weissbrich; Sibylle Schneider-Schaulies; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

4.  Vesicular stomatitis virus as a treatment for colorectal cancer.

Authors:  J H Stewart; M Ahmed; S A Northrup; M Willingham; D S Lyles
Journal:  Cancer Gene Ther       Date:  2011-09-02       Impact factor: 5.987

5.  Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors.

Authors:  Kevin T Beier; Arpiar Saunders; Ian A Oldenburg; Kazunari Miyamichi; Nazia Akhtar; Liqun Luo; Sean P J Whelan; Bernardo Sabatini; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

6.  Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

Authors:  M Ahmed; D S Lyles
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 7.  Hitchhiking on the neuronal highway: Mechanisms of transsynaptic specificity.

Authors:  Kevin T Beier
Journal:  J Chem Neuroanat       Date:  2019-05-07       Impact factor: 3.052

8.  Some attenuated variants of vesicular stomatitis virus show enhanced oncolytic activity against human glioblastoma cells relative to normal brain cells.

Authors:  Guido Wollmann; Vitaliy Rogulin; Ian Simon; John K Rose; Anthony N van den Pol
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

9.  Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus.

Authors:  Brooke L Carey; Maryam Ahmed; Shelby Puckett; Douglas S Lyles
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Implications for a regulated replication of Borna disease virus in brains of experimentally infected Lewis rats.

Authors:  Doris Porombka; Wolfgang Baumgärtner; Markus Eickmann; Christiane Herden
Journal:  Virus Genes       Date:  2008-02-14       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.